GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

Perimeter Medical Imaging AI PINK.V · CAD

Materials · TSX Venture · 🇨🇦 Canada

Compare

0.15

0.00%

Close of 9 Nov 2026, in CAD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

$2.3m

FY2015FY2025

Net income

−$12.9m

FY2015FY2025

Free cash flow

−$9.4m

FY2015FY2025

Shareholders' equity

$4.1m

FY2015FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2017FY2016FY2015
Revenue$2.3m$846,194$544,643$132,766$8,052—————
Research and development$4.9m$6.6m$7.0m$5.5m$3.2m$468,308$643,352———
Operating income−$12.9m−$18.7m−$22.3m−$16.1m−$11.4m−$11.7m−$13.0m−$123,400−$137,200−$184,400
Net income−$12.9m−$13.4m−$18.9m−$3.6m−$11.9m−$8.0m−$10.5m$1.6m−$4.8m−$291,700
Diluted earnings per share-0.20-0.21-0.29-0.06-0.20-0.19-0.140.12-0.36-0.02

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2017FY2016FY2015
Total assets$6.7m$14.3m$27.1m$34.6m$7.1m$13.2m$2.6m$3.2m$1.6m$6.4m
Cash and short-term investments——$18.4m$28.4m$3.7m$11.7m$1.2m$3.2m$1.6m$894,700
Total liabilities$2.6m$3.9m$7.1m$8.5m$1.8m$2.4m$19.0m$270,600$229,700$152,600
Debt——$254,350$325,676$313,167$400,805$14.2m———
Shareholders' equity$4.1m$10.5m$19.9m$26.1m$5.3m$10.8m−$16.5m$2.9m$1.4m$6.2m
Shares outstanding65m65m65m61m59m42m73m13m13m—

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2017FY2016FY2015
Cash from operations−$9.3m−$14.7m−$19.8m−$11.9m−$13.9m−$8.3m−$5.8m−$79,600−$61,500−$89,900
Capital spending−$128,195−$2.2m−$640,430−$2.0m−$2.1m—−$46,947———
Free cash flow−$9.4m−$16.9m−$20.5m−$13.9m−$16.0m−$8.3m−$5.8m−$79,600−$61,500−$89,900

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue$503,156$384,604$711,546$536,100$505,796$550,269$293,133$208,420
Operating income−$2.8m−$3.0m−$2.0m−$2.7m−$3.9m−$4.3m−$4.4m−$4.4m
Net income−$2.5m−$3.0m−$2.0m−$2.7m−$3.9m−$4.3m−$3.4m−$4.7m
Diluted earnings per share-0.04-0.05-0.03-0.04-0.06-0.07-0.05-0.07
Cash from operations−$2.0m−$2.0m−$1.0m−$1.0m−$2.0m−$3.0m−$3.0m−$4.0m
Capital spending——————−$1.0m—
Free cash flow——————−$4.0m—
Total assets$10.5m$4.7m$6.7m$6.0m$6.9m$8.6m$14.3m$15.7m
Shareholders' equity$4.2m$1.6m$4.1m$3.5m$4.5m$6.5m$10.5m$12.8m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue158.9%——
Operating income-7.1%2.1%53.0%
Net income53.3%10.0%46.1%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-1004.6%-1829.9%——
Net margin-835.3%-1276.1%——

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2017FY2016FY2015
Price to earnings-1.3-1.3-3.0-20.0-14.6-10.0-1.10.8-0.2-0.7
Price to sales7.121.1105.3———————

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 6-to-1 reverse split · 18 Feb 2014
  • 10-to-1 reverse split · 16 Apr 2003
  • 5-to-1 reverse split · 26 May 1999
  • 7-to-1 reverse split · 11 Jul 1997
  • 10-to-1 reverse split · 8 Oct 1992

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.